ARCHIVES

Unclear Whether Clinical Trials Benefit Patients, Review Finds

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

Bladder Cancer “Headquarters” Grant Program Seeks Applications For High Priority Research

March 1, 1974

ASCO/AUA Suggest 5-ARIs To Cut Prostate Cancer Risk

February 27, 2009

Prostate Cancer Council Calls For Long-Term Screening Research

September 10, 1993

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996